We measured surface levels of NGAL-R and CD38 (at the same time point for each patient) in CD19+/CD5+ blood samples from 37 untreated CLL patients (including 10 newly diagnosed patients). The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.